The CCL2/CCR2 axis mediates TAM infiltration, while the application of a natural CCR2 antagonist decreased the number of TAMs in the tumor stroma and shifted them towards the M1-like phenotype, further elevating the number of CD8+ T cells [147]. The gene discussed is CCL2; the disease is neoplasm.